Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients

NCT ID: NCT04276714

Last Updated: 2022-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-22

Study Completion Date

2021-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At the early stage of the amputation, the residual limb presents post-surgical fluctuations related to post-operative phase, which would need a frequent prosthetic adjustment. In most cases, the volume of residual limb is constant from 12 to 18 months after surgery. However, some daily fluctuations could appear due to an underlying vascular disease for example, which could be painful and impact the quality of life with a constant need of prosthetics adjustment. The goal of this study is to assess the effectiveness of a system-adjusted fitting in comparison with a standard fitting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With the " multiple N-of-1 trial " study type, pain, quality of life, functional effects and the patient satisfaction with assistive technology will be assessed for four weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation Adult Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Single Case Experimental Design : multiple N of 1 trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adjustable socket

First week of the study is with adjustable socket

Group Type EXPERIMENTAL

Socket without Revofit system

Intervention Type OTHER

All the tests are evaluate during one week with the classical type of fittings

Socket with Revofit system

Intervention Type OTHER

All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)

Classical socket

First week of the study is with classical socket

Group Type EXPERIMENTAL

Socket without Revofit system

Intervention Type OTHER

All the tests are evaluate during one week with the classical type of fittings

Socket with Revofit system

Intervention Type OTHER

All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Socket without Revofit system

All the tests are evaluate during one week with the classical type of fittings

Intervention Type OTHER

Socket with Revofit system

All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years old and above
* Above knee or below knee amputation (irrespective of etiology and time from amputation)
* Residual limb pain
* Prosthetic with classic fitting
* Fluctuations of residual limb requiring prosthetic adaptation (stump cotton sock, wedgning fitting …)
* Recipients or registered with a social security scheme
* Informed consent form signed beforehand

Exclusion Criteria

* Patient with peripheral neuropathies contraindicating the use of Revofit system
* Pregnant woman, nursing mother or parturiant
* Patient in detention by judicial or administrative decision
* Patient undergoing psychiatric compulsory care
* Patient in a health or social institution for purposes other than research
* Legally protected person
* Patient unable to express their consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mickaël Dinomais

Role: PRINCIPAL_INVESTIGATOR

MD University hospital Angers

Yoann RONZI

Role: PRINCIPAL_INVESTIGATOR

MD

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DIMONAIS

Angers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

49RC19_0129

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transfemoral Powered Foot and Physical Therapy Study
NCT03625921 ACTIVE_NOT_RECRUITING NA
Aerofit Post Market Investigation
NCT05925712 COMPLETED NA
AMP Step Wedge Trial
NCT05021679 COMPLETED NA